Mauritius vs South-East Asia (WHO region): Treatment success rate for patients treated for MDR-TB

Mauritius
100.0%
in 2022
South-East Asia (WHO region)
77.0%
in 2022
Mauritius rank
1st
South-East Asia (WHO region) rank
2nd

Treatment success rate for patients treated for MDR-TB over time

  • Mauritius
  • South-East Asia (WHO region)
020406080100200620142022

How they compare

Mauritius currently reports 100.0% against 77.0% in South-East Asia (WHO region), a difference of 23.0%.

That makes Mauritius's figure about 1.3 times South-East Asia (WHO region)'s.

The two have swapped places 9 times across 14 shared years of data; in 2006 it was South-East Asia (WHO region) ahead.

Mauritius ranks 1st and South-East Asia (WHO region) ranks 2nd of 163 countries.

Mauritius has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Mauritius South-East Asia (WHO region) Difference Ahead
2000s 87.5% 60.5% 27.0% Mauritius
2010s 64.6% 53.8% 10.9% Mauritius
2020s 75.0% 75.0% 0.0%

Averages of every year both report within each decade.

Frequently asked questions

Which has higher treatment success rate for patients treated for mdr-tb, Mauritius or South-East Asia (WHO region)?
Mauritius, at 100.0% against 77.0% in South-East Asia (WHO region) as of 2022.
What is the difference in treatment success rate for patients treated for mdr-tb between Mauritius and South-East Asia (WHO region)?
23.0%, with Mauritius ahead.
How many years of comparable data are there for Mauritius and South-East Asia (WHO region)?
14 years are reported by both, from 2006 to 2022.
How do Mauritius and South-East Asia (WHO region) rank globally for treatment success rate for patients treated for mdr-tb?
Mauritius ranks 1st and South-East Asia (WHO region) ranks 2nd of 163 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Mauritius vs South-East Asia (WHO region): Treatment success rate for patients treated for MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 17 September 2026, from https://health.statizoid.com/compare/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/mauritius/south-east-asia-who-region/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/mauritius/south-east-asia-who-region/">Mauritius vs South-East Asia (WHO region): Treatment success rate for patients treated for MDR-TB</a> — Statizoid

About this data

Indicator
Treatment success rate for patients treated for MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
175 places, 2,495 data points, 1999–2022
Last refreshed